Scri Development Innovations, Llc

This study compares a new drug combination (BMS-986489) against the standard drug durvalumab as follow-up treatment after chemoradiation for people with limited-stage small cell lung cancer. About 250 adults will take part. The goal is to see if the new combo helps people live lo…

This study tests a combination of two drugs, tucatinib and Doxil, in people with HER2+ breast cancer that has spread or cannot be removed. The goal is to see how well the combo shrinks tumors and what side effects it causes. About 36 adults with this type of cancer will take part…

This study tests a combination of two cancer drugs (fruquintinib and FOLFIRI) as a second treatment option for people with metastatic colorectal cancer whose first treatment stopped working. About 60 adults will receive the drug combo to see if it can slow cancer growth and how s…

This study compares two approaches for people newly diagnosed with multiple myeloma: a drug combination (elranatamab and daratumumab) versus a stem cell transplant followed by maintenance drugs. The goal is to see which method better eliminates cancer cells deep in the bone marro…

This study tests whether two drugs, teclistamab and talquetamab, can be given safely in a clinic or doctor's office instead of requiring a hospital stay for multiple myeloma patients. About 100 adults who have already tried other treatments will receive these drugs along with med…